US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 2.720
  • +0.070+2.64%
Close Nov 27 16:00 ET
  • 2.730
  • +0.010+0.37%
Post 19:36 ET
174.73MMarket Cap-1754P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
37.50%24.85M
68.75%27.67M
32.53%24.35M
10.15%75.65M
16.77%22.81M
6.87%18.07M
6.52%16.39M
9.09%18.37M
21.24%68.68M
4.14%19.53M
Selling and administrative expenses
4.82%4.96M
24.94%5.91M
-19.63%5.23M
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
10.04%20.83M
9.41%5.7M
-General and administrative expense
4.82%4.96M
24.94%5.91M
-19.63%5.23M
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
10.04%20.83M
9.41%5.7M
Research and development costs
49.09%19.89M
86.51%21.76M
61.18%19.11M
14.63%54.85M
29.96%17.98M
9.43%13.34M
16.58%11.67M
0.36%11.86M
26.85%47.85M
2.11%13.84M
Operating profit
-37.50%-24.85M
-68.75%-27.67M
-32.53%-24.35M
-10.15%-75.65M
-16.77%-22.81M
-6.87%-18.07M
-6.52%-16.39M
-9.09%-18.37M
-21.24%-68.68M
-4.14%-19.53M
Net non-operating interest income expense
-74.44%362K
-24.31%635K
5.01%1.05M
133.01%4.5M
53.37%1.25M
92.13%1.42M
161.37%839K
1,565.00%999K
816.11%1.93M
1,795.35%815K
Non-operating interest income
-24.95%1.78M
26.09%2.03M
78.90%2.37M
257.04%7.84M
135.00%2.53M
221.44%2.37M
401.56%1.61M
2,111.67%1.33M
940.28%2.2M
2,404.65%1.08M
Non-operating interest expense
48.58%1.42M
80.93%1.4M
303.96%1.33M
1,172.14%3.33M
--1.28M
--953K
--771K
--328K
--262K
----
Other net income (expense)
-505.00%-81K
89.29%-3K
-50.00%-51K
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
-68.78%-319K
535.00%174K
Other non- operating income (expenses)
-505.00%-81K
89.29%-3K
-50.00%-51K
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
-68.78%-319K
535.00%174K
Income before tax
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
Income tax
Net income
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
Net income continuous Operations
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
Minority interest income
Net income attributable to the parent company
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
Basic earnings per share
-34.48%-0.39
-25.71%-0.44
5.00%-0.38
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
0.00%-1.78
-147.06%-0.42
Diluted earnings per share
-34.48%-0.39
-25.71%-0.44
5.00%-0.38
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
0.00%-1.78
-147.06%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 37.50%24.85M68.75%27.67M32.53%24.35M10.15%75.65M16.77%22.81M6.87%18.07M6.52%16.39M9.09%18.37M21.24%68.68M4.14%19.53M
Selling and administrative expenses 4.82%4.96M24.94%5.91M-19.63%5.23M-0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M10.04%20.83M9.41%5.7M
-General and administrative expense 4.82%4.96M24.94%5.91M-19.63%5.23M-0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M10.04%20.83M9.41%5.7M
Research and development costs 49.09%19.89M86.51%21.76M61.18%19.11M14.63%54.85M29.96%17.98M9.43%13.34M16.58%11.67M0.36%11.86M26.85%47.85M2.11%13.84M
Operating profit -37.50%-24.85M-68.75%-27.67M-32.53%-24.35M-10.15%-75.65M-16.77%-22.81M-6.87%-18.07M-6.52%-16.39M-9.09%-18.37M-21.24%-68.68M-4.14%-19.53M
Net non-operating interest income expense -74.44%362K-24.31%635K5.01%1.05M133.01%4.5M53.37%1.25M92.13%1.42M161.37%839K1,565.00%999K816.11%1.93M1,795.35%815K
Non-operating interest income -24.95%1.78M26.09%2.03M78.90%2.37M257.04%7.84M135.00%2.53M221.44%2.37M401.56%1.61M2,111.67%1.33M940.28%2.2M2,404.65%1.08M
Non-operating interest expense 48.58%1.42M80.93%1.4M303.96%1.33M1,172.14%3.33M--1.28M--953K--771K--328K--262K----
Other net income (expense) -505.00%-81K89.29%-3K-50.00%-51K91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K-68.78%-319K535.00%174K
Other non- operating income (expenses) -505.00%-81K89.29%-3K-50.00%-51K91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K-68.78%-319K535.00%174K
Income before tax -47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M
Income tax
Net income -47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M
Net income continuous Operations -47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M
Minority interest income
Net income attributable to the parent company -47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M
Basic earnings per share -34.48%-0.39-25.71%-0.445.00%-0.3823.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.40.00%-1.78-147.06%-0.42
Diluted earnings per share -34.48%-0.39-25.71%-0.445.00%-0.3823.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.40.00%-1.78-147.06%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data